Literature DB >> 34820927

Objective validity of patient-reported symptoms in aspirin-exacerbated respiratory disease patients.

Pooja P Patel1, Jing Cui2,3, Katherine N Cahill4, Tanya M Laidlaw2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34820927      PMCID： PMC8810664          DOI： 10.1111/cea.14062

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  7 in total

1.  A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.

Authors:  Geneva A DeGregorio; Joseph Singer; Katherine N Cahill; Tanya Laidlaw
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-02

2.  Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.

Authors:  Marek L Kowalski; Ioana Agache; Sevim Bavbek; Arzu Bakirtas; Miguel Blanca; Grażyna Bochenek; Matteo Bonini; Enrico Heffler; Ludger Klimek; Tanya M Laidlaw; Joaquim Mullol; Ewa Niżankowska-Mogilnicka; Hae-Sim Park; Marek Sanak; Mario Sanchez-Borges; Silvia Sanchez-Garcia; Glenis Scadding; Masami Taniguchi; Maria J Torres; Andrew A White; Aleksandra Wardzyńska
Journal:  Allergy       Date:  2018-10-02       Impact factor: 13.146

Review 3.  Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.

Authors:  Tanya M Laidlaw; Katherine N Cahill
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

4.  Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis.

Authors:  N H Ta; C Hopkins; J Vennik; C Philpott
Journal:  Rhinology       Date:  2019-10-01       Impact factor: 3.681

Review 5.  Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review.

Authors:  Zachary Farhood; Rodney J Schlosser; Madeline E Pearse; Kristina A Storck; Shaun A Nguyen; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2015-11-26       Impact factor: 3.858

6.  Psychometric validity of the 22-item Sinonasal Outcome Test.

Authors:  C Hopkins; S Gillett; R Slack; V J Lund; J P Browne
Journal:  Clin Otolaryngol       Date:  2009-10       Impact factor: 2.597

7.  Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease.

Authors:  Patrick J Staso; Pingsheng Wu; Tanya M Laidlaw; Katherine N Cahill
Journal:  Ann Allergy Asthma Immunol       Date:  2021-03-27       Impact factor: 6.248
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.